Wenhao Xu

3.0k total citations
124 papers, 1.8k citations indexed

About

Wenhao Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Wenhao Xu has authored 124 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 58 papers in Pulmonary and Respiratory Medicine and 31 papers in Cancer Research. Recurrent topics in Wenhao Xu's work include Ferroptosis and cancer prognosis (41 papers), Renal cell carcinoma treatment (34 papers) and Epigenetics and DNA Methylation (19 papers). Wenhao Xu is often cited by papers focused on Ferroptosis and cancer prognosis (41 papers), Renal cell carcinoma treatment (34 papers) and Epigenetics and DNA Methylation (19 papers). Wenhao Xu collaborates with scholars based in China, United States and United Kingdom. Wenhao Xu's co-authors include Dingwei Ye, Yuanyuan Qu, Hailiang Zhang, Fangning Wan, Wangrui Liu, Aihetaimujiang Anwaier, Xi Tian, Yue Xu, Jim Geiser and Glen K. Andrews and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wenhao Xu

110 papers receiving 1.8k citations

Peers

Countries citing papers authored by Wenhao Xu

Since Specialization

Citations

This map shows the geographic impact of Wenhao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhao Xu more than expected).

Fields of papers citing papers by Wenhao Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenhao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhao Xu. The network helps show where Wenhao Xu may publish in the future.

Co-authorship network of co-authors of Wenhao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenhao Xu. A scholar is included among the top collaborators of Wenhao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenhao Xu. Wenhao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spatially segregated APOE⁺ macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma 2025 ·Theranostics ·(unknown), (unknown), Zhongyuan Wang, Aihetaimujiang Anwaier, (unknown), Xi Tian, (unknown), Jianfeng Yang, Hailiang Zhang, Dingwei Ye, Wenhao Xu	2
2	Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF‐κB and TGF‐β Signaling Pathways 2025 ·Advanced Science ·Shiqi Ye, Jian‐Feng Xiang, Siqi Zhou, (unknown), Aihetaimujiang Anwaier, Kun Chang, Gang Wei, (unknown), Xi Tian, (unknown), Jun Chen, Wei Zhang, (unknown), Midie Xu, Dingwei Ye, (unknown), Tao Wang, Hailiang Zhang, Wenhao Xu	0
3	A multimodal deep learning framework for predicting sunitinib response in advanced clear cell renal cell carcinoma 2025 ·View ·Xi Tian, Jun Chen, (unknown), Xiaohang Liu, Aihetaimujiang Anwaier, Shiqi Ye, Kun Chang, Yuanyuan Qu, Yajia Gu, Hai‐Liang Zhang, Dingwei Ye, Wenhao Xu	0
4	Genomic landscape and molecular evolutionary trajectories of renal epithelioid angiomyolipoma and benign angiomyolipoma 2025 ·Neoplasia ·Aihetaimujiang Anwaier, Yuanyuan Qu, Shiqi Ye, Xi Tian, (unknown), Siqi Zhou, Guo-Hai Shi, (unknown), Hailiang Zhang, Dingwei Ye, Wenhao Xu	0
5	Macroporous hydrogel-based mRNA cancer vaccine for in situ recruitment and modulation of dendritic cells 2025 ·Acta Biomaterialia ·(unknown), Yusheng Liu, Wenhao Xu, (unknown), (unknown), (unknown), (unknown), Cecília Leal, Hua Wang	2
6	Neutrophil to high-density lipoprotein cholesterol ratio predicts deep venous thrombosis in spontaneous intracerebral hemorrhage 2025 ·Scientific Reports ·Wenhao Xu, Peng Wang, (unknown), Jialing He, Yuxin Zheng, Yuyang Liu, Liyuan Peng, (unknown), Yuning Feng, (unknown), Fang Fang, Yu Zhang	0
7	TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study 2024 ·SHILAP Revista de lepidopterología ·Aimin Jiang, (unknown), (unknown), Wenqiang Liu, Qiwei Yang, Yu Fang, (unknown), Xiaofeng Wu, Huamao Ye, Bicheng Ye, Shunxiang Gao, Le Qu, Wenhao Xu, Peng Luo, Linhui Wang	3
8	Elucidating the role of lipid interactions in stabilizing the membrane protein KcsA 2024 ·Biophysical Journal ·(unknown), (unknown), (unknown), Yuchen Wang, Jinhui Chen, Wenhao Xu, Erin Baker	1
9	Unlocking Cardioprotective Potential of Gut Microbiome: Exploring Therapeutic Strategies 2024 ·Journal of Microbiology and Biotechnology ·(unknown), Fantao Meng, Zhen Wang, Wenhao Xu	3
10	Dissecting the Implications of Calumenin in Malignancy and Heterogeneity of the Microenvironment of Clear Cell Renal Cell Carcinoma Using Multi-Omics Data 2024 ·PubMed ·Xinqiang Wu, Zhi Shang, (unknown), Wenhao Xu, (unknown), (unknown), (unknown), (unknown), Jiaqi Su, Jian‐Yuan Zhao, Hailiang Zhang, (unknown), Yuanyuan Qu, Dingwei Ye	1
11	Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma 2024 ·SHILAP Revista de lepidopterología ·Wenhao Xu, (unknown), Xi Tian, Shiqi Ye, Shiyin Wei, Jun Wang, Aihetaimujiang Anwaier, Yuanyuan Qu, Wangrui Liu, Kun Chang, Hailiang Zhang, Dingwei Ye	27
12	Enhancing the electric charge output in LiNbO₃-based piezoelectric pressure sensors 2024 ·RSC Advances ·Wenhao Xu, Wenping Geng, (unknown), (unknown), Zihan Wang, (unknown), Xiaojun Qiao, Yichi Zhang, Xiujian Chou	5
13	Systematic multiomics analysis and in vitro experiments suggest that ITGA5 could serve as a promising therapeutic target for ccRCC 2024 ·Cancer Cell International ·(unknown), Xi Tian, (unknown), (unknown), Shiqi Ye, Yue Wang, (unknown), Yiyun Huang, Aihetaimujiang Anwaier, Pang Yao, Yijia Chen, Kaihui Wu, Yifei Liu, Wenhao Xu, Hailiang Zhang, Dingwei Ye	0
14	Dual Photo‐Responsive Diphenylacetylene Enables PET In‐Situ Upcycling with Reverse Enhanced UV‐Resistance and Strength 2023 ·Angewandte Chemie International Edition ·Lixia Fan, Lin Chen, (unknown), Wenhao Xu, Xiu‐Li Wang, Shimei Xu, Yu‐Zhong Wang	27
15	Dual Photo‐Responsive Diphenylacetylene Enables PET In‐Situ Upcycling with Reverse Enhanced UV‐Resistance and Strength 2023 ·Angewandte Chemie ·Lixia Fan, Lin Chen, (unknown), Wenhao Xu, Xiu‐Li Wang, Shimei Xu, Yu‐Zhong Wang	1
16	Insights into adsorption behavior and mechanism of Cu(II) onto biodegradable and conventional microplastics: Effect of aging process and environmental factors 2023 ·Environmental Pollution ·Wei Huang, Jie Zhang, Zhenrui Zhang, (unknown), Wenhao Xu, Xinghui Xia	25
17	CCL19: a novel prognostic chemokine modulates the tumor immune microenvironment and outcomes of cancers 2023 ·Aging ·Qiang Gu, (unknown), Cong Chen, Zhi Wang, Wenhao Xu, Jiarong Zhang, Shiyin Wei, Jianfeng Yang, (unknown)	11
18	LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer 2021 ·Cell Death and Disease ·Wenjie Luo, Jun Wang, Wenhao Xu, Chunguang Ma, Fangning Wan, Yongqiang Huang, Mengfei Yao, Hailiang Zhang, Yuanyuan Qu, Dingwei Ye, Yiping Zhu	131
19	Targeting CPT1B as a potential therapeutic strategy in castration‐resistant and enzalutamide‐resistant prostate cancer 2020 ·The Prostate ·Mierxiati Abudurexiti, Wenkai Zhu, (unknown), Jun Wang, Wenhao Xu, Yongqiang Huang, Yao Zhu, Guohai Shi, Hailiang Zhang, Yiping Zhu, Yijun Shen, Bo Dai, Fangning Wan, Guowen Lin, Dingwei Ye	40
20	Low‐serum prostate‐specific antigen level predicts poor outcomes in patients with primary neuroendocrine prostate cancer 2019 ·The Prostate ·Jun Wang, Wenhao Xu, Mierxiati Abudurexiti, Yongqiang Huang, Wei Yu, Guowen Lin, Bo Dai, Stephen J. Freedland, Xiaojian Qin, Yao Zhu, Dingwei Ye	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact